Emslo Tablet
Marketer
Ampiron Pharmaceuticals
Salt Composition
Solifenacin (5mg)
Overview Emslo Tablet
Darifenacin (Emslo Tablet's active ingredient) is a medication blocking muscarinic receptors, indicated for managing overactive bladder. This treatment alleviates symptoms such as frequent, urgent urination, and incontinence. Dosage and duration should strictly adhere to your physician's instructions. It can be administered with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinuing treatment prematurely may exacerbate symptoms, so consult your doctor before stopping. Complete the prescribed course for optimal results. Potential side effects include dry mouth, constipation, nausea, and urinary tract infection. Increased water intake can help mitigate these. Drowsiness or blurred vision are possible; avoid driving if affected. Before starting treatment, disclose all other medications and pre-existing health issues, including pregnancy or breastfeeding. Patients with liver or kidney impairment require careful monitoring and regular check-ups under their doctor's supervision.
Uses of Emslo Tablet
Managing overactive bladder (OAB) symptoms
Major Benefits of Emslo Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Emslo Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Emslo Tablet can be taken with or without food, although consistent timing is recommended.
Common Side effects of Emslo Tablet:
- Dryness in mouth
- Constipation
- Blurred vision
- Nausea
- Upset stomach
- Urinary tract infection
How to use Emslo Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Emslo Tablet. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Emslo Tablet can be administered with or without food, though consistent timing is recommended.
How Emslo Tablet works:
Emslo tablets exert an antimuscarinic effect, relieving urinary urgency, frequency, and incontinence by reducing bladder muscle spasms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Emslo Tablet with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Emslo Tablet during pregnancy might pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Emslo Tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant. However, prolonged Emslo Tablet use may decrease breast milk supply and potentially lead to constipation, xerostomia, and urinary tract infection in the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by Emslo Tablet side effects, including blurred vision and drowsiness.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Emslo Tablet, potentially requiring dosage modification. Dialysis patients should avoid Emslo Tablet; physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use Emslo tablets cautiously, potentially requiring dosage modification under medical supervision. Emslo tablets are contraindicated in those with severe hepatic dysfunction.
What if you forget to take Emslo Tablet :
Should you forget to take your Emslo Tablet, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Emslo Tablet
| Label | Value |
|---|---|
| Type of Compound | Quinuclidine-based tetrahydroisoquinoline compound |
| Potential for Dependence | None. |
| Type of Medication | The study of the urinary tract and male reproductive system. |
| Mechanism of Action | Specific M3 muscarinic receptor antagonist (urology) |



